{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"pseudohyperaldosteronism-type-2","columns":[{"gene":"","key":"population-f26e0cca552d3ca3518a","label":"Hypertension, early-onset, autosomal dominant, with severe exacerbationin pregnancy","mondoId":"MONDO:0011517","onsetQualifier":null,"originColumnKey":"MONDO:0011517/OMIM:605115","originalViews":[{"key":"MONDO:0011517/OMIM:605115","label":"Hypertension, early-onset, autosomal dominant, with severe exacerbationin pregnancy","scopeLabel":"OMIM:605115","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["52e316777de6eb416067a685ba7fa68c61794b102a7518bf78cc4bb4f936b6b1","7d31ae8f0eb6bbd5ce6192e9b8994b638f81f4729568c2caec71e239b36e3265","b637fe3c13149e8e569ddb78ecdf0aa4146491349b3570d52c4ea27a881faebc"],"recordQualifiers":{},"scopeLabel":"OMIM:605115","sourceIds":["OMIM:605115"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-f26e0cca552d3ca3518a"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0004319","HP:0003351","HP:0000822"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":3,"sourceGroups":{"omim":3}},"features":[{"hpoId":"HP:0004319","label":"Decreased circulating aldosterone concentration","primary":true},{"hpoId":"HP:0003351","label":"Decreased circulating renin concentration","primary":true},{"hpoId":"HP:0000822","label":"Hypertension","primary":true}],"ledeHtml":"Hypertension due to gain-of-function mutations in the mineralocorticoid receptor is a rare genetic hypertension characterized by a familial severe hypertension with an onset before age 20 years, associated with suppressed plasma renin and low aldosterone levels in the presence of low or normal levels of the mineralocorticoid aldosterone, that is highly resistant to antihypertensive medication. During pregnancy, there is a marked exacerbation of hypertension, accompanied by low serum potassium levels and undetectable aldosterone levels, but without signs of preeclampsia, requiring early delivery.","mondoId":"MONDO:0011517","node":{"canonicalSlug":"pseudohyperaldosteronism-type-2","comparisons":[{"documentSha256":"fedc48a73cf36434903cc245620b2a0359d355b0abadf50da1251c5b4f85ff5e","key":"legacy-pseudohyperaldosteronism-type-2","kind":"legacy","label":"pseudohyperaldosteronism type 2","memberIds":["MONDO:0011517"],"mondoId":"MONDO:0011517","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/pseudohyperaldosteronism-type-2.fedc48a73cf36434903cc245620b2a0359d355b0abadf50da1251c5b4f85ff5e.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Pseudohyperaldosteronism type 2","originalSourceId":"ORPHA:88660","paragraphs":["Hypertension due to gain-of-function mutations in the mineralocorticoid receptor is a rare genetic hypertension characterized by a familial severe hypertension with an onset before age 20 years, associated with suppressed plasma renin and low aldosterone levels in the presence of low or normal levels of the mineralocorticoid aldosterone, that is highly resistant to antihypertensive medication. During pregnancy, there is a marked exacerbation of hypertension, accompanied by low serum potassium levels and undetectable aldosterone levels, but without signs of preeclampsia, requiring early delivery."],"rawAttribution":"MONDO:0011517","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-21T17:03:27Z","upstream":"ORPHA:88660","url":"https://rarediseases.info.nih.gov/diseases/19093"},"ownColumnKeys":["population-f26e0cca552d3ca3518a"],"publication":"published","relationships":[{"kind":"parent","label":"hereditary disease","mondoId":"MONDO:0003847","slug":null},{"kind":"parent","label":"pregnancy disorder","mondoId":"MONDO:0024575","slug":null}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"reported","key":"52e316777de6eb416067a685ba7fa68c61794b102a7518bf78cc4bb4f936b6b1","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:605115","disease_name":"Hypertension, early-onset, autosomal dominant, with severe exacerbationin pregnancy","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0000822","is_excluded":false,"label":"Hypertension","onset_id":null,"reference":"OMIM:605115","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"7d31ae8f0eb6bbd5ce6192e9b8994b638f81f4729568c2caec71e239b36e3265","raw":{"aspect":"P","body_system":"endocrine","disease_id":"OMIM:605115","disease_name":"Hypertension, early-onset, autosomal dominant, with severe exacerbationin pregnancy","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0004319","is_excluded":false,"label":"Decreased circulating aldosterone concentration","onset_id":null,"reference":"OMIM:605115","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"b637fe3c13149e8e569ddb78ecdf0aa4146491349b3570d52c4ea27a881faebc","raw":{"aspect":"P","body_system":"endocrine","disease_id":"OMIM:605115","disease_name":"Hypertension, early-onset, autosomal dominant, with severe exacerbationin pregnancy","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0003351","is_excluded":false,"label":"Decreased circulating renin concentration","onset_id":null,"reference":"OMIM:605115","source_release":"2026-06-23"},"sourceGroups":["omim"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/19093\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0011517\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>ORPHA:88660</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Hypertension due to gain-of-function mutations in the mineralocorticoid receptor is a rare genetic hypertension characterized by a familial severe hypertension with an onset before age 20 years, associated with suppressed plasma renin and low aldosterone levels in the presence of low or normal levels of the mineralocorticoid aldosterone, that is highly resistant to antihypertensive medication. During pregnancy, there is a marked exacerbation of hypertension, accompanied by low serum potassium levels and undetectable aldosterone levels, but without signs of preeclampsia, requiring early delivery.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/19093\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"pseudohyperaldosteronism-type-2","sourceDocuments":[{"name":"GARD: Pseudohyperaldosteronism type 2","reviewed":null,"source_release":"2026-10-21T17:03:27Z","url":"https://rarediseases.info.nih.gov/diseases/19093"},{"name":"MONDO: pseudohyperaldosteronism type 2","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0011517"}],"sourceNote":"","synonyms":["early-onset hypertension with exacerbation in pregnancy","hypertension due to gain-of-function mutations in the mineralocorticoid receptor","hypertension, early-onset, autosomal dominant, with exacerbation in pregnancy"],"takeawayHtml":"","title":"pseudohyperaldosteronism type 2"},"schemaVersion":1}
